![Clinical Perspective: Treatment of Aggressive B Cell Lymphomas with FDA-Approved CAR-T Cell Therapies - ScienceDirect Clinical Perspective: Treatment of Aggressive B Cell Lymphomas with FDA-Approved CAR-T Cell Therapies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001620305931-fx1.jpg)
Clinical Perspective: Treatment of Aggressive B Cell Lymphomas with FDA-Approved CAR-T Cell Therapies - ScienceDirect
![New agents and regimens for diffuse large B cell lymphoma | Journal of Hematology & Oncology | Full Text New agents and regimens for diffuse large B cell lymphoma | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-020-01011-z/MediaObjects/13045_2020_1011_Fig1_HTML.png)
New agents and regimens for diffuse large B cell lymphoma | Journal of Hematology & Oncology | Full Text
![Cancers | Free Full-Text | High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients Cancers | Free Full-Text | High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients](https://www.mdpi.com/cancers/cancers-14-00338/article_deploy/html/images/cancers-14-00338-g001.png)
Cancers | Free Full-Text | High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients
![Diffuse large B‐cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment - Liu - 2019 - American Journal of Hematology - Wiley Online Library Diffuse large B‐cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment - Liu - 2019 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/41cddd3f-a5ba-4324-867c-79f4c7f1fd18/ajh25460-fig-0001-m.jpg)
Diffuse large B‐cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment - Liu - 2019 - American Journal of Hematology - Wiley Online Library
![Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma | Scientific Reports Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-78508-7/MediaObjects/41598_2020_78508_Fig1_HTML.jpg)
Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma | Scientific Reports
![Frontiers | Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies Frontiers | Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies](https://www.frontiersin.org/files/Articles/426970/fonc-08-00556-HTML/image_m/fonc-08-00556-g001.jpg)
Frontiers | Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies
![Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study - The Lancet ... Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study - The Lancet ...](https://www.thelancet.com/cms/attachment/a6d44114-4163-44eb-865e-9403d3861cc5/gr1_lrg.gif)
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study - The Lancet ...
![Applied Sciences | Free Full-Text | High-Grade B-Cell Lymphoma Not Otherwise Specified (HGBL, NOS) in the Maxillary Sinus Mimicking Periapical Inflammation: Case Report and Review of the Literature Applied Sciences | Free Full-Text | High-Grade B-Cell Lymphoma Not Otherwise Specified (HGBL, NOS) in the Maxillary Sinus Mimicking Periapical Inflammation: Case Report and Review of the Literature](https://www.mdpi.com/applsci/applsci-11-08803/article_deploy/html/images/applsci-11-08803-g001.png)
Applied Sciences | Free Full-Text | High-Grade B-Cell Lymphoma Not Otherwise Specified (HGBL, NOS) in the Maxillary Sinus Mimicking Periapical Inflammation: Case Report and Review of the Literature
STAT3 mutations are present in aggressive B-cell lymphomas including a subset of diffuse large B-cell lymphomas with CD30 expression | Haematologica
![A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit | SpringerLink A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00428-019-02637-2/MediaObjects/428_2019_2637_Fig3_HTML.png)